Advancing Multiple Sclerosis Treatment and Outcomes: Access, Adherence and Site of Care Obstacles

Advancing Multiple Sclerosis Treatment and Outcomes: Access, Adherence and Site of Care Obstacles

Publication date: Nov 16, 2019

Earn CME: https://www.naccme.com/program/19-hqc-101-2

This webcast features presentations that discuss overcoming obstacles to patient care, with a focus on access, adherence, and site of care barriers.

© 2019 NACCME, an HMP Company

Concepts Keywords
African Americans Multiple Sclerosis Treatment
Ahmadi Insurance companies conversation
Air Food problem
Angola Energy
Autopsy Diagnosis Multiple sclerosis
Axons Important disease
Benign Consistent multiple sclerosis
Black Box Warning Pretty good disease
Blood History multiple sclerosis
Blood Pressure Thyroid disease
Blurry Vision Progression disease
Brain Symptoms inflammation
Brain Stem Diabetes
Cancer Treatments flu
Caucus Lesions waves inflammation
Central Nervous System Costs disease
Cerebellum Pain
Cigarette Smoking Risk breast cancers
Clinical Trial Waas depression
Clinical Trials Neurologic dysfunction
Clyde Mild neurologic dysfunction
Crypt Inflammatory changes
Depression Frequent infections
Diabetes Lifelong disease
Diamond Trauma headaches
Disability Lupus
DIT Clinical mononucleosis
Emery Medication flu
Energy Syndrome
Enzyme Hypertension diabetes
Epstein Barr Virus Intravenous infusions
Equator Health
Evoked Potentials Multiple sclerosis
Fatigue Clinical pharmacology
FDA Autoimmune diseases
FINA Pharmaceutical industry
Fina Pharmacy
Flute Clinical trial
Ford Adherence
Frequency Multiple sclerosis research
Gal
Gastrointestinal
GATT
Gene
Generics
Genetic
Head Trauma
Hospital
Hypertension
Identical Twins
Immune Suppression
Immune System
Inflammation
Insurance
Iran
ISI
Island
Lesion
Liver
Logic
Loss Function
Lupus
Lyme Disease
Mab
Macrophages
Malignancies
Memory
Metabolism
Metric
Migraine
Molecule
Mono
Mononucleosis
Multiple Sclerosis
Numbness
Optic Nerve
Orel
Pain
Pathogenesis
Pathology
Pennsylvania
Philadelphia
Physician
PML
Pregnancy
Progressive
Proposition
Questionnaire
Relapse
Sleep
Smoking
Soup
Spasticity
Spectrum
Spinal Cord
Spinal Fluid
Symptom
Syndrome
Tate
Temperate
Therapeutic Range
Thes
United States
Virus
Viruses
Vitamin
Webcast
White
White Matter

Semantics

Type Source Name
disease MESH Multiple Sclerosis
disease DOID Multiple Sclerosis
drug DRUGBANK Coenzyme M
gene UNIPROT IMMT

Similar

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *